Jun 17, 2026 07:31AM
Jun 9, 2026 02:00PM
May 8, 2026 06:56AM
May 7, 2026 04:24PM
Apr 13, 2026 06:41AM
Apr 10, 2026 12:26PM
Apr 10, 2026 07:00AM Verastem presents two-year follow-up data for ovarian cancer therapy
Mar 27, 2026 04:17PM
Mar 11, 2026 04:11PM
Mar 5, 2026 10:06AM
Mar 4, 2026 04:13PM
Feb 4, 2026 07:31AM
Feb 4, 2026 06:52AM
Feb 4, 2026 06:15AM H.C. Wainwright Assumes Verastem (VSTM) at Buy
Dec 31, 2025 06:32AM
Dec 15, 2025 04:01PM
Nov 5, 2025 10:03AM
Nov 4, 2025 07:59AM
Oct 21, 2025 10:08AM
Oct 21, 2025 06:48AM
Oct 20, 2025 07:40AM Cantor Fitzgerald Reiterates Overweight Rating on Verastem (VSTM) on Dual-Program Growth Potential
Oct 16, 2025 06:24AM
Sep 11, 2025 08:18AM
Aug 18, 2025 06:36AM
Aug 14, 2025 05:33AM
Aug 13, 2025 04:29PM
Aug 8, 2025 08:48AM
Jul 24, 2025 07:30AM Verastem gets fast track status for pancreatic cancer drug VS-7375
Jul 11, 2025 04:12PM
Jul 1, 2025 12:33PM
Jun 30, 2025 04:02PM
Jun 24, 2025 04:02PM
Jun 3, 2025 07:08AM
Jun 2, 2025 09:40AM
May 22, 2025 05:07PM Verastem Oncology (VSTM) announces positive results from phase 1/2 trial on Avutometinib plus Defactinib
May 20, 2025 08:33AM
May 13, 2025 06:27PM
May 8, 2025 01:44PM
May 8, 2025 11:47AM
Apr 29, 2025 06:28AM
Apr 25, 2025 09:00AM
Apr 23, 2025 04:08PM Verastem Oncology (VSTM) Announces U.S. IND Clearance of VS-7375
Apr 10, 2025 03:34AM
Mar 24, 2025 07:26AM
Mar 24, 2025 06:40AM
Mar 21, 2025 06:33AM
Jan 24, 2025 08:22AM
Jan 23, 2025 07:31AM
Jan 16, 2025 06:04AM BTIG Reiterates Buy Rating on Verastem (VSTM)
Jan 15, 2025 07:30AM

415,737 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All